Program Overview

Pulmonary arterial hypertension (PAH) is a progressive disease associated with poor clinical outcomes and poor patient survival despite ongoing advances in treatment. At this time, there is a significant need to educate nurses on pharmacologic options for PAH along with patient-related clinical considerations. The purpose of this symposium is to focus on several important aspects of PAH management including a review of the pathophysiology, classification, predictors of disease progression and clinical outcomes of PAH; a discussion of clinical trial data on existing and emerging therapeutics for the management of PAH; and a review of effective strategies to improve therapeutic and clinical outcomes in patients with PAH.

Target Audience

This activity is intended for nurse practitioners, nurses and other providers involved in the management of patients with pulmonary arterial hypertension (PAH).

Learning Objectives
Upon completion of the educational activity, participants should be able to:
  • Review the pathophysiology, classification, functional capacity classification, predictors of disease progression and clinical outcomes of pulmonary arterial hypertension (PAH)
  • Discuss the safety, tolerability, administration, and general use of existing and emerging therapeutics for the management of PAH
  • Identify strategies to optimize therapy and improve outcomes in patients with pulmonary arterial hypertension (PAH)
Featured Faculty
Martha Kingman, FNP-C, DNP
Nurse Practitioner, Pulmonary Services, Heart and Lung Center
University of Texas Southwestern Medical Center
Dallas, Texas
Sandra Lombardi, RN
Pulmonary Hypertension Clinical Nurse Coordinator
University of California, San Diego

La Jolla, California

12aada63afba6947d43ec91f2cf884c7.png

Accreditation
CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare

Nurse Practitioners
AKH, Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number: 030803.
This program is accredited for 1.0 contact hour(s) which includes 1.0 hour(s) of pharmacology. Program ID #21714.

Nurses
AKH, Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is awarded 1.0 Contact Hours.

Commercial Support
This activity is supported by educational grants from Actelion Pharmaceuticals US, Inc. and Bayer HealthCare Pharmaceuticals, Inc.

Criteria for Success
Statements of credit will be awarded based on the participant's attendance, participation in the pre/post-test and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at https://akhinc.formstack.com/forms/pah. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this CE activity, please contact AKH Inc. at tbrignoni@akhcme.com.

Americans with Disabilities Act
AKH Inc, Advancing Knowledge in Healthcare fully intends to comply with the legal requirements of the Americans with Disabilities Act. If you need assistance, please notify AKH at 904-683-8843 at least two weeks prior to the activity.